nodes	percent_of_prediction	percent_of_DWPC	metapath
Ezogabine—CYP2A6—Tretinoin—peripheral nervous system neoplasm	0.215	0.585	CbGbCtD
Ezogabine—UGT1A1—Etoposide—peripheral nervous system neoplasm	0.152	0.415	CbGbCtD
Ezogabine—KCNQ4—cochlear duct of membranous labyrinth—peripheral nervous system neoplasm	0.0923	0.46	CbGeAlD
Ezogabine—KCNQ4—cochlea—peripheral nervous system neoplasm	0.0467	0.233	CbGeAlD
Ezogabine—KCNQ4—internal ear—peripheral nervous system neoplasm	0.0443	0.221	CbGeAlD
Ezogabine—KCNQ2—brainstem—peripheral nervous system neoplasm	0.0058	0.0289	CbGeAlD
Ezogabine—KCNQ4—cerebellum—peripheral nervous system neoplasm	0.00398	0.0198	CbGeAlD
Ezogabine—KCNQ3—cerebellum—peripheral nervous system neoplasm	0.0031	0.0155	CbGeAlD
Ezogabine—KCNQ2—cerebellum—peripheral nervous system neoplasm	0.00286	0.0143	CbGeAlD
Ezogabine—CYP2A6—cerebellum—peripheral nervous system neoplasm	0.00142	0.00708	CbGeAlD
Ezogabine—KCNQ3—L1CAM interactions—CNTN6—peripheral nervous system neoplasm	0.00116	0.0653	CbGpPWpGaD
Ezogabine—KCNQ2—L1CAM interactions—CNTN6—peripheral nervous system neoplasm	0.00116	0.0653	CbGpPWpGaD
Ezogabine—UGT1A1—Codeine and Morphine Metabolism—ABCB1—peripheral nervous system neoplasm	0.000952	0.0537	CbGpPWpGaD
Ezogabine—Somnolence—Isotretinoin—peripheral nervous system neoplasm	0.000833	0.00201	CcSEcCtD
Ezogabine—Somnolence—Tretinoin—peripheral nervous system neoplasm	0.000833	0.00201	CcSEcCtD
Ezogabine—Dyspepsia—Topotecan—peripheral nervous system neoplasm	0.000831	0.00201	CcSEcCtD
Ezogabine—Paraesthesia—Melphalan—peripheral nervous system neoplasm	0.00083	0.002	CcSEcCtD
Ezogabine—Gait disturbance—Doxorubicin—peripheral nervous system neoplasm	0.000825	0.00199	CcSEcCtD
Ezogabine—Dyspepsia—Tretinoin—peripheral nervous system neoplasm	0.000825	0.00199	CcSEcCtD
Ezogabine—Dyspepsia—Isotretinoin—peripheral nervous system neoplasm	0.000825	0.00199	CcSEcCtD
Ezogabine—Dyspnoea—Melphalan—peripheral nervous system neoplasm	0.000824	0.00199	CcSEcCtD
Ezogabine—Hepatobiliary disease—Etoposide—peripheral nervous system neoplasm	0.000822	0.00198	CcSEcCtD
Ezogabine—Visual impairment—Cisplatin—peripheral nervous system neoplasm	0.00082	0.00198	CcSEcCtD
Ezogabine—Coordination abnormal—Doxorubicin—peripheral nervous system neoplasm	0.00082	0.00198	CcSEcCtD
Ezogabine—Vision blurred—Alitretinoin—peripheral nervous system neoplasm	0.00082	0.00198	CcSEcCtD
Ezogabine—Gastrointestinal disorder—Topotecan—peripheral nervous system neoplasm	0.000815	0.00197	CcSEcCtD
Ezogabine—Tremor—Alitretinoin—peripheral nervous system neoplasm	0.000815	0.00197	CcSEcCtD
Ezogabine—Fatigue—Topotecan—peripheral nervous system neoplasm	0.000814	0.00196	CcSEcCtD
Ezogabine—Dyspepsia—Melphalan—peripheral nervous system neoplasm	0.000814	0.00196	CcSEcCtD
Ezogabine—Gastrointestinal disorder—Tretinoin—peripheral nervous system neoplasm	0.000809	0.00195	CcSEcCtD
Ezogabine—Gastrointestinal disorder—Isotretinoin—peripheral nervous system neoplasm	0.000809	0.00195	CcSEcCtD
Ezogabine—Fatigue—Tretinoin—peripheral nervous system neoplasm	0.000808	0.00195	CcSEcCtD
Ezogabine—Fatigue—Isotretinoin—peripheral nervous system neoplasm	0.000808	0.00195	CcSEcCtD
Ezogabine—Constipation—Topotecan—peripheral nervous system neoplasm	0.000807	0.00195	CcSEcCtD
Ezogabine—UGT1A9—Irinotecan Pathway—BCHE—peripheral nervous system neoplasm	0.000807	0.0456	CbGpPWpGaD
Ezogabine—UGT1A1—Irinotecan Pathway—BCHE—peripheral nervous system neoplasm	0.000807	0.0456	CbGpPWpGaD
Ezogabine—Ill-defined disorder—Alitretinoin—peripheral nervous system neoplasm	0.000807	0.00195	CcSEcCtD
Ezogabine—Constipation—Isotretinoin—peripheral nervous system neoplasm	0.000801	0.00193	CcSEcCtD
Ezogabine—Constipation—Tretinoin—peripheral nervous system neoplasm	0.000801	0.00193	CcSEcCtD
Ezogabine—Gastrointestinal disorder—Melphalan—peripheral nervous system neoplasm	0.000798	0.00193	CcSEcCtD
Ezogabine—Fatigue—Melphalan—peripheral nervous system neoplasm	0.000797	0.00192	CcSEcCtD
Ezogabine—Eye disorder—Cisplatin—peripheral nervous system neoplasm	0.000796	0.00192	CcSEcCtD
Ezogabine—Coma—Epirubicin—peripheral nervous system neoplasm	0.000796	0.00192	CcSEcCtD
Ezogabine—Discomfort—Dactinomycin—peripheral nervous system neoplasm	0.000789	0.0019	CcSEcCtD
Ezogabine—Malaise—Alitretinoin—peripheral nervous system neoplasm	0.000784	0.00189	CcSEcCtD
Ezogabine—Syncope—Alitretinoin—peripheral nervous system neoplasm	0.00078	0.00188	CcSEcCtD
Ezogabine—Feeling abnormal—Topotecan—peripheral nervous system neoplasm	0.000778	0.00188	CcSEcCtD
Ezogabine—Feeling abnormal—Tretinoin—peripheral nervous system neoplasm	0.000772	0.00186	CcSEcCtD
Ezogabine—Feeling abnormal—Isotretinoin—peripheral nervous system neoplasm	0.000772	0.00186	CcSEcCtD
Ezogabine—Urinary tract disorder—Etoposide—peripheral nervous system neoplasm	0.00077	0.00186	CcSEcCtD
Ezogabine—Urethral disorder—Etoposide—peripheral nervous system neoplasm	0.000765	0.00184	CcSEcCtD
Ezogabine—Loss of consciousness—Alitretinoin—peripheral nervous system neoplasm	0.000764	0.00184	CcSEcCtD
Ezogabine—Infection—Dactinomycin—peripheral nervous system neoplasm	0.000761	0.00184	CcSEcCtD
Ezogabine—Vertigo—Vincristine—peripheral nervous system neoplasm	0.000753	0.00182	CcSEcCtD
Ezogabine—Alopecia—Cisplatin—peripheral nervous system neoplasm	0.000752	0.00182	CcSEcCtD
Ezogabine—Leukopenia—Vincristine—peripheral nervous system neoplasm	0.00075	0.00181	CcSEcCtD
Ezogabine—Thrombocytopenia—Dactinomycin—peripheral nervous system neoplasm	0.00075	0.00181	CcSEcCtD
Ezogabine—Malnutrition—Cisplatin—peripheral nervous system neoplasm	0.000741	0.00179	CcSEcCtD
Ezogabine—Anxiety—Alitretinoin—peripheral nervous system neoplasm	0.000738	0.00178	CcSEcCtD
Ezogabine—Coma—Doxorubicin—peripheral nervous system neoplasm	0.000736	0.00178	CcSEcCtD
Ezogabine—Discomfort—Alitretinoin—peripheral nervous system neoplasm	0.000732	0.00177	CcSEcCtD
Ezogabine—Eye disorder—Etoposide—peripheral nervous system neoplasm	0.000729	0.00176	CcSEcCtD
Ezogabine—Dry mouth—Alitretinoin—peripheral nervous system neoplasm	0.000724	0.00175	CcSEcCtD
Ezogabine—Confusional state—Alitretinoin—peripheral nervous system neoplasm	0.000716	0.00173	CcSEcCtD
Ezogabine—Muscle spasms—Cisplatin—peripheral nervous system neoplasm	0.000713	0.00172	CcSEcCtD
Ezogabine—Infection—Alitretinoin—peripheral nervous system neoplasm	0.000705	0.0017	CcSEcCtD
Ezogabine—Vision blurred—Cisplatin—peripheral nervous system neoplasm	0.000698	0.00169	CcSEcCtD
Ezogabine—Shock—Alitretinoin—peripheral nervous system neoplasm	0.000698	0.00169	CcSEcCtD
Ezogabine—Nervous system disorder—Alitretinoin—peripheral nervous system neoplasm	0.000696	0.00168	CcSEcCtD
Ezogabine—Thrombocytopenia—Alitretinoin—peripheral nervous system neoplasm	0.000695	0.00168	CcSEcCtD
Ezogabine—Tremor—Cisplatin—peripheral nervous system neoplasm	0.000694	0.00168	CcSEcCtD
Ezogabine—Alopecia—Etoposide—peripheral nervous system neoplasm	0.000689	0.00166	CcSEcCtD
Ezogabine—Ill-defined disorder—Cisplatin—peripheral nervous system neoplasm	0.000688	0.00166	CcSEcCtD
Ezogabine—Hyperhidrosis—Alitretinoin—peripheral nervous system neoplasm	0.000686	0.00166	CcSEcCtD
Ezogabine—Infection—Vincristine—peripheral nervous system neoplasm	0.00068	0.00164	CcSEcCtD
Ezogabine—Asthenia—Topotecan—peripheral nervous system neoplasm	0.000677	0.00163	CcSEcCtD
Ezogabine—Increased appetite—Epirubicin—peripheral nervous system neoplasm	0.000673	0.00162	CcSEcCtD
Ezogabine—Asthenia—Tretinoin—peripheral nervous system neoplasm	0.000672	0.00162	CcSEcCtD
Ezogabine—Asthenia—Isotretinoin—peripheral nervous system neoplasm	0.000672	0.00162	CcSEcCtD
Ezogabine—Nervous system disorder—Vincristine—peripheral nervous system neoplasm	0.000671	0.00162	CcSEcCtD
Ezogabine—Thrombocytopenia—Vincristine—peripheral nervous system neoplasm	0.00067	0.00162	CcSEcCtD
Ezogabine—Malaise—Cisplatin—peripheral nervous system neoplasm	0.000668	0.00161	CcSEcCtD
Ezogabine—Leukopenia—Cisplatin—peripheral nervous system neoplasm	0.000663	0.0016	CcSEcCtD
Ezogabine—Asthenia—Melphalan—peripheral nervous system neoplasm	0.000663	0.0016	CcSEcCtD
Ezogabine—Hyperhidrosis—Vincristine—peripheral nervous system neoplasm	0.000661	0.0016	CcSEcCtD
Ezogabine—Fatigue—Dactinomycin—peripheral nervous system neoplasm	0.00066	0.00159	CcSEcCtD
Ezogabine—Muscle spasms—Etoposide—peripheral nervous system neoplasm	0.000653	0.00158	CcSEcCtD
Ezogabine—Paraesthesia—Alitretinoin—peripheral nervous system neoplasm	0.000637	0.00154	CcSEcCtD
Ezogabine—Dyspnoea—Alitretinoin—peripheral nervous system neoplasm	0.000633	0.00153	CcSEcCtD
Ezogabine—Osteoarthritis—Epirubicin—peripheral nervous system neoplasm	0.000632	0.00153	CcSEcCtD
Ezogabine—Diplopia—Epirubicin—peripheral nervous system neoplasm	0.000632	0.00153	CcSEcCtD
Ezogabine—Somnolence—Alitretinoin—peripheral nervous system neoplasm	0.000631	0.00152	CcSEcCtD
Ezogabine—Feeling abnormal—Dactinomycin—peripheral nervous system neoplasm	0.000631	0.00152	CcSEcCtD
Ezogabine—Ill-defined disorder—Etoposide—peripheral nervous system neoplasm	0.00063	0.00152	CcSEcCtD
Ezogabine—Anxiety—Cisplatin—peripheral nervous system neoplasm	0.000629	0.00152	CcSEcCtD
Ezogabine—Dyspepsia—Alitretinoin—peripheral nervous system neoplasm	0.000625	0.00151	CcSEcCtD
Ezogabine—Dizziness—Topotecan—peripheral nervous system neoplasm	0.000624	0.00151	CcSEcCtD
Ezogabine—Discomfort—Cisplatin—peripheral nervous system neoplasm	0.000623	0.0015	CcSEcCtD
Ezogabine—Increased appetite—Doxorubicin—peripheral nervous system neoplasm	0.000622	0.0015	CcSEcCtD
Ezogabine—Dizziness—Tretinoin—peripheral nervous system neoplasm	0.000619	0.00149	CcSEcCtD
Ezogabine—Dizziness—Isotretinoin—peripheral nervous system neoplasm	0.000619	0.00149	CcSEcCtD
Ezogabine—Paraesthesia—Vincristine—peripheral nervous system neoplasm	0.000614	0.00148	CcSEcCtD
Ezogabine—Gastrointestinal disorder—Alitretinoin—peripheral nervous system neoplasm	0.000613	0.00148	CcSEcCtD
Ezogabine—Malaise—Etoposide—peripheral nervous system neoplasm	0.000612	0.00148	CcSEcCtD
Ezogabine—Fatigue—Alitretinoin—peripheral nervous system neoplasm	0.000612	0.00148	CcSEcCtD
Ezogabine—Vertigo—Etoposide—peripheral nervous system neoplasm	0.00061	0.00147	CcSEcCtD
Ezogabine—Leukopenia—Etoposide—peripheral nervous system neoplasm	0.000608	0.00147	CcSEcCtD
Ezogabine—Constipation—Alitretinoin—peripheral nervous system neoplasm	0.000607	0.00146	CcSEcCtD
Ezogabine—Infection—Cisplatin—peripheral nervous system neoplasm	0.000601	0.00145	CcSEcCtD
Ezogabine—Loss of consciousness—Etoposide—peripheral nervous system neoplasm	0.000597	0.00144	CcSEcCtD
Ezogabine—Rash—Topotecan—peripheral nervous system neoplasm	0.000595	0.00144	CcSEcCtD
Ezogabine—Dermatitis—Topotecan—peripheral nervous system neoplasm	0.000595	0.00144	CcSEcCtD
Ezogabine—Nervous system disorder—Cisplatin—peripheral nervous system neoplasm	0.000593	0.00143	CcSEcCtD
Ezogabine—Thrombocytopenia—Cisplatin—peripheral nervous system neoplasm	0.000592	0.00143	CcSEcCtD
Ezogabine—Rash—Tretinoin—peripheral nervous system neoplasm	0.000591	0.00143	CcSEcCtD
Ezogabine—Rash—Isotretinoin—peripheral nervous system neoplasm	0.000591	0.00143	CcSEcCtD
Ezogabine—Gastrointestinal disorder—Vincristine—peripheral nervous system neoplasm	0.000591	0.00143	CcSEcCtD
Ezogabine—Dermatitis—Tretinoin—peripheral nervous system neoplasm	0.00059	0.00142	CcSEcCtD
Ezogabine—Dermatitis—Isotretinoin—peripheral nervous system neoplasm	0.00059	0.00142	CcSEcCtD
Ezogabine—Fatigue—Vincristine—peripheral nervous system neoplasm	0.00059	0.00142	CcSEcCtD
Ezogabine—Feeling abnormal—Alitretinoin—peripheral nervous system neoplasm	0.000585	0.00141	CcSEcCtD
Ezogabine—Constipation—Vincristine—peripheral nervous system neoplasm	0.000585	0.00141	CcSEcCtD
Ezogabine—Diplopia—Doxorubicin—peripheral nervous system neoplasm	0.000585	0.00141	CcSEcCtD
Ezogabine—Osteoarthritis—Doxorubicin—peripheral nervous system neoplasm	0.000585	0.00141	CcSEcCtD
Ezogabine—Hyperhidrosis—Cisplatin—peripheral nervous system neoplasm	0.000585	0.00141	CcSEcCtD
Ezogabine—Liver function test abnormal—Epirubicin—peripheral nervous system neoplasm	0.000583	0.00141	CcSEcCtD
Ezogabine—Rash—Melphalan—peripheral nervous system neoplasm	0.000583	0.00141	CcSEcCtD
Ezogabine—Dermatitis—Melphalan—peripheral nervous system neoplasm	0.000582	0.00141	CcSEcCtD
Ezogabine—Discomfort—Etoposide—peripheral nervous system neoplasm	0.000571	0.00138	CcSEcCtD
Ezogabine—KCNQ3—L1CAM interactions—NCAM1—peripheral nervous system neoplasm	0.000564	0.0319	CbGpPWpGaD
Ezogabine—KCNQ2—L1CAM interactions—NCAM1—peripheral nervous system neoplasm	0.000564	0.0319	CbGpPWpGaD
Ezogabine—Nausea—Topotecan—peripheral nervous system neoplasm	0.000561	0.00135	CcSEcCtD
Ezogabine—Confusional state—Etoposide—peripheral nervous system neoplasm	0.000559	0.00135	CcSEcCtD
Ezogabine—Nausea—Tretinoin—peripheral nervous system neoplasm	0.000556	0.00134	CcSEcCtD
Ezogabine—Nausea—Isotretinoin—peripheral nervous system neoplasm	0.000556	0.00134	CcSEcCtD
Ezogabine—Infection—Etoposide—peripheral nervous system neoplasm	0.000551	0.00133	CcSEcCtD
Ezogabine—Asthenia—Dactinomycin—peripheral nervous system neoplasm	0.000549	0.00133	CcSEcCtD
Ezogabine—Nausea—Melphalan—peripheral nervous system neoplasm	0.000549	0.00133	CcSEcCtD
Ezogabine—UGT1A4—Constitutive Androstane Receptor Pathway—ABCB1—peripheral nervous system neoplasm	0.000546	0.0309	CbGpPWpGaD
Ezogabine—Influenza—Epirubicin—peripheral nervous system neoplasm	0.000546	0.00132	CcSEcCtD
Ezogabine—Dysphagia—Epirubicin—peripheral nervous system neoplasm	0.000546	0.00132	CcSEcCtD
Ezogabine—Paraesthesia—Cisplatin—peripheral nervous system neoplasm	0.000543	0.00131	CcSEcCtD
Ezogabine—Thrombocytopenia—Etoposide—peripheral nervous system neoplasm	0.000543	0.00131	CcSEcCtD
Ezogabine—Liver function test abnormal—Doxorubicin—peripheral nervous system neoplasm	0.00054	0.0013	CcSEcCtD
Ezogabine—Dyspnoea—Cisplatin—peripheral nervous system neoplasm	0.000539	0.0013	CcSEcCtD
Ezogabine—Hyperhidrosis—Etoposide—peripheral nervous system neoplasm	0.000536	0.00129	CcSEcCtD
Ezogabine—Gastrointestinal disorder—Cisplatin—peripheral nervous system neoplasm	0.000522	0.00126	CcSEcCtD
Ezogabine—Dysuria—Epirubicin—peripheral nervous system neoplasm	0.000511	0.00123	CcSEcCtD
Ezogabine—Neutropenia—Epirubicin—peripheral nervous system neoplasm	0.000511	0.00123	CcSEcCtD
Ezogabine—Asthenia—Alitretinoin—peripheral nervous system neoplasm	0.000509	0.00123	CcSEcCtD
Ezogabine—Dysphagia—Doxorubicin—peripheral nervous system neoplasm	0.000505	0.00122	CcSEcCtD
Ezogabine—Influenza—Doxorubicin—peripheral nervous system neoplasm	0.000505	0.00122	CcSEcCtD
Ezogabine—Feeling abnormal—Cisplatin—peripheral nervous system neoplasm	0.000498	0.0012	CcSEcCtD
Ezogabine—Paraesthesia—Etoposide—peripheral nervous system neoplasm	0.000498	0.0012	CcSEcCtD
Ezogabine—Weight increased—Epirubicin—peripheral nervous system neoplasm	0.000497	0.0012	CcSEcCtD
Ezogabine—Dyspnoea—Etoposide—peripheral nervous system neoplasm	0.000494	0.00119	CcSEcCtD
Ezogabine—Somnolence—Etoposide—peripheral nervous system neoplasm	0.000493	0.00119	CcSEcCtD
Ezogabine—Asthenia—Vincristine—peripheral nervous system neoplasm	0.000491	0.00118	CcSEcCtD
Ezogabine—Infestation NOS—Epirubicin—peripheral nervous system neoplasm	0.000487	0.00118	CcSEcCtD
Ezogabine—Infestation—Epirubicin—peripheral nervous system neoplasm	0.000487	0.00118	CcSEcCtD
Ezogabine—Rash—Dactinomycin—peripheral nervous system neoplasm	0.000483	0.00116	CcSEcCtD
Ezogabine—Gastrointestinal disorder—Etoposide—peripheral nervous system neoplasm	0.000478	0.00115	CcSEcCtD
Ezogabine—Fatigue—Etoposide—peripheral nervous system neoplasm	0.000478	0.00115	CcSEcCtD
Ezogabine—Constipation—Etoposide—peripheral nervous system neoplasm	0.000474	0.00114	CcSEcCtD
Ezogabine—Neutropenia—Doxorubicin—peripheral nervous system neoplasm	0.000473	0.00114	CcSEcCtD
Ezogabine—Dysuria—Doxorubicin—peripheral nervous system neoplasm	0.000473	0.00114	CcSEcCtD
Ezogabine—Dizziness—Alitretinoin—peripheral nervous system neoplasm	0.000469	0.00113	CcSEcCtD
Ezogabine—Haematuria—Epirubicin—peripheral nervous system neoplasm	0.000464	0.00112	CcSEcCtD
Ezogabine—Hepatobiliary disease—Epirubicin—peripheral nervous system neoplasm	0.000461	0.00111	CcSEcCtD
Ezogabine—Weight increased—Doxorubicin—peripheral nervous system neoplasm	0.00046	0.00111	CcSEcCtD
Ezogabine—Feeling abnormal—Etoposide—peripheral nervous system neoplasm	0.000457	0.0011	CcSEcCtD
Ezogabine—Nausea—Dactinomycin—peripheral nervous system neoplasm	0.000455	0.0011	CcSEcCtD
Ezogabine—UGT1A3—Constitutive Androstane Receptor Pathway—ABCB1—peripheral nervous system neoplasm	0.000454	0.0257	CbGpPWpGaD
Ezogabine—Dizziness—Vincristine—peripheral nervous system neoplasm	0.000452	0.00109	CcSEcCtD
Ezogabine—Infestation—Doxorubicin—peripheral nervous system neoplasm	0.000451	0.00109	CcSEcCtD
Ezogabine—Infestation NOS—Doxorubicin—peripheral nervous system neoplasm	0.000451	0.00109	CcSEcCtD
Ezogabine—Rash—Alitretinoin—peripheral nervous system neoplasm	0.000448	0.00108	CcSEcCtD
Ezogabine—Dermatitis—Alitretinoin—peripheral nervous system neoplasm	0.000447	0.00108	CcSEcCtD
Ezogabine—KCNQ3—Axon guidance—CNTN6—peripheral nervous system neoplasm	0.000437	0.0247	CbGpPWpGaD
Ezogabine—KCNQ2—Axon guidance—CNTN6—peripheral nervous system neoplasm	0.000437	0.0247	CbGpPWpGaD
Ezogabine—Asthenia—Cisplatin—peripheral nervous system neoplasm	0.000434	0.00105	CcSEcCtD
Ezogabine—Urinary tract disorder—Epirubicin—peripheral nervous system neoplasm	0.000432	0.00104	CcSEcCtD
Ezogabine—Rash—Vincristine—peripheral nervous system neoplasm	0.000431	0.00104	CcSEcCtD
Ezogabine—Dermatitis—Vincristine—peripheral nervous system neoplasm	0.000431	0.00104	CcSEcCtD
Ezogabine—Oedema peripheral—Epirubicin—peripheral nervous system neoplasm	0.000431	0.00104	CcSEcCtD
Ezogabine—Haematuria—Doxorubicin—peripheral nervous system neoplasm	0.00043	0.00104	CcSEcCtD
Ezogabine—Urethral disorder—Epirubicin—peripheral nervous system neoplasm	0.000429	0.00103	CcSEcCtD
Ezogabine—Hepatobiliary disease—Doxorubicin—peripheral nervous system neoplasm	0.000426	0.00103	CcSEcCtD
Ezogabine—Nausea—Alitretinoin—peripheral nervous system neoplasm	0.000422	0.00102	CcSEcCtD
Ezogabine—Visual impairment—Epirubicin—peripheral nervous system neoplasm	0.000421	0.00102	CcSEcCtD
Ezogabine—Eye disorder—Epirubicin—peripheral nervous system neoplasm	0.000409	0.000986	CcSEcCtD
Ezogabine—Nausea—Vincristine—peripheral nervous system neoplasm	0.000406	0.00098	CcSEcCtD
Ezogabine—Urinary tract disorder—Doxorubicin—peripheral nervous system neoplasm	0.0004	0.000964	CcSEcCtD
Ezogabine—Oedema peripheral—Doxorubicin—peripheral nervous system neoplasm	0.000399	0.000962	CcSEcCtD
Ezogabine—Asthenia—Etoposide—peripheral nervous system neoplasm	0.000398	0.000959	CcSEcCtD
Ezogabine—Urethral disorder—Doxorubicin—peripheral nervous system neoplasm	0.000397	0.000957	CcSEcCtD
Ezogabine—Visual impairment—Doxorubicin—peripheral nervous system neoplasm	0.00039	0.000941	CcSEcCtD
Ezogabine—Alopecia—Epirubicin—peripheral nervous system neoplasm	0.000386	0.000932	CcSEcCtD
Ezogabine—Mental disorder—Epirubicin—peripheral nervous system neoplasm	0.000383	0.000924	CcSEcCtD
Ezogabine—Rash—Cisplatin—peripheral nervous system neoplasm	0.000381	0.00092	CcSEcCtD
Ezogabine—Dermatitis—Cisplatin—peripheral nervous system neoplasm	0.000381	0.000919	CcSEcCtD
Ezogabine—Malnutrition—Epirubicin—peripheral nervous system neoplasm	0.000381	0.000918	CcSEcCtD
Ezogabine—Eye disorder—Doxorubicin—peripheral nervous system neoplasm	0.000378	0.000912	CcSEcCtD
Ezogabine—KCNQ5—Neuronal System—BCHE—peripheral nervous system neoplasm	0.000369	0.0208	CbGpPWpGaD
Ezogabine—KCNQ4—Neuronal System—BCHE—peripheral nervous system neoplasm	0.000369	0.0208	CbGpPWpGaD
Ezogabine—Dizziness—Etoposide—peripheral nervous system neoplasm	0.000366	0.000884	CcSEcCtD
Ezogabine—Muscle spasms—Epirubicin—peripheral nervous system neoplasm	0.000366	0.000883	CcSEcCtD
Ezogabine—Nausea—Cisplatin—peripheral nervous system neoplasm	0.000359	0.000867	CcSEcCtD
Ezogabine—Vision blurred—Epirubicin—peripheral nervous system neoplasm	0.000359	0.000866	CcSEcCtD
Ezogabine—Alopecia—Doxorubicin—peripheral nervous system neoplasm	0.000357	0.000863	CcSEcCtD
Ezogabine—Mental disorder—Doxorubicin—peripheral nervous system neoplasm	0.000354	0.000855	CcSEcCtD
Ezogabine—Ill-defined disorder—Epirubicin—peripheral nervous system neoplasm	0.000353	0.000852	CcSEcCtD
Ezogabine—Malnutrition—Doxorubicin—peripheral nervous system neoplasm	0.000352	0.00085	CcSEcCtD
Ezogabine—Rash—Etoposide—peripheral nervous system neoplasm	0.000349	0.000843	CcSEcCtD
Ezogabine—Dermatitis—Etoposide—peripheral nervous system neoplasm	0.000349	0.000842	CcSEcCtD
Ezogabine—Malaise—Epirubicin—peripheral nervous system neoplasm	0.000343	0.000828	CcSEcCtD
Ezogabine—Vertigo—Epirubicin—peripheral nervous system neoplasm	0.000342	0.000825	CcSEcCtD
Ezogabine—Syncope—Epirubicin—peripheral nervous system neoplasm	0.000341	0.000824	CcSEcCtD
Ezogabine—Leukopenia—Epirubicin—peripheral nervous system neoplasm	0.000341	0.000822	CcSEcCtD
Ezogabine—Muscle spasms—Doxorubicin—peripheral nervous system neoplasm	0.000339	0.000817	CcSEcCtD
Ezogabine—Loss of consciousness—Epirubicin—peripheral nervous system neoplasm	0.000335	0.000807	CcSEcCtD
Ezogabine—Vision blurred—Doxorubicin—peripheral nervous system neoplasm	0.000332	0.000801	CcSEcCtD
Ezogabine—Nausea—Etoposide—peripheral nervous system neoplasm	0.000329	0.000794	CcSEcCtD
Ezogabine—Ill-defined disorder—Doxorubicin—peripheral nervous system neoplasm	0.000327	0.000788	CcSEcCtD
Ezogabine—Anxiety—Epirubicin—peripheral nervous system neoplasm	0.000323	0.000779	CcSEcCtD
Ezogabine—Discomfort—Epirubicin—peripheral nervous system neoplasm	0.00032	0.000773	CcSEcCtD
Ezogabine—Malaise—Doxorubicin—peripheral nervous system neoplasm	0.000318	0.000766	CcSEcCtD
Ezogabine—Dry mouth—Epirubicin—peripheral nervous system neoplasm	0.000317	0.000765	CcSEcCtD
Ezogabine—Vertigo—Doxorubicin—peripheral nervous system neoplasm	0.000316	0.000763	CcSEcCtD
Ezogabine—Syncope—Doxorubicin—peripheral nervous system neoplasm	0.000316	0.000762	CcSEcCtD
Ezogabine—Leukopenia—Doxorubicin—peripheral nervous system neoplasm	0.000315	0.000761	CcSEcCtD
Ezogabine—UGT1A1—Constitutive Androstane Receptor Pathway—ABCB1—peripheral nervous system neoplasm	0.000314	0.0177	CbGpPWpGaD
Ezogabine—UGT1A9—Constitutive Androstane Receptor Pathway—ABCB1—peripheral nervous system neoplasm	0.000314	0.0177	CbGpPWpGaD
Ezogabine—Confusional state—Epirubicin—peripheral nervous system neoplasm	0.000313	0.000756	CcSEcCtD
Ezogabine—KCNQ2—Developmental Biology—CNTN6—peripheral nervous system neoplasm	0.000312	0.0176	CbGpPWpGaD
Ezogabine—KCNQ3—Developmental Biology—CNTN6—peripheral nervous system neoplasm	0.000312	0.0176	CbGpPWpGaD
Ezogabine—Loss of consciousness—Doxorubicin—peripheral nervous system neoplasm	0.00031	0.000747	CcSEcCtD
Ezogabine—Infection—Epirubicin—peripheral nervous system neoplasm	0.000309	0.000745	CcSEcCtD
Ezogabine—Shock—Epirubicin—peripheral nervous system neoplasm	0.000306	0.000737	CcSEcCtD
Ezogabine—Nervous system disorder—Epirubicin—peripheral nervous system neoplasm	0.000305	0.000735	CcSEcCtD
Ezogabine—Thrombocytopenia—Epirubicin—peripheral nervous system neoplasm	0.000304	0.000734	CcSEcCtD
Ezogabine—Hyperhidrosis—Epirubicin—peripheral nervous system neoplasm	0.0003	0.000725	CcSEcCtD
Ezogabine—Anxiety—Doxorubicin—peripheral nervous system neoplasm	0.000299	0.000721	CcSEcCtD
Ezogabine—Discomfort—Doxorubicin—peripheral nervous system neoplasm	0.000296	0.000715	CcSEcCtD
Ezogabine—Dry mouth—Doxorubicin—peripheral nervous system neoplasm	0.000293	0.000708	CcSEcCtD
Ezogabine—Confusional state—Doxorubicin—peripheral nervous system neoplasm	0.00029	0.000699	CcSEcCtD
Ezogabine—Infection—Doxorubicin—peripheral nervous system neoplasm	0.000286	0.000689	CcSEcCtD
Ezogabine—UGT1A9—Fatty acid, triacylglycerol, and ketone body metabolism—HSD17B12—peripheral nervous system neoplasm	0.000283	0.016	CbGpPWpGaD
Ezogabine—Shock—Doxorubicin—peripheral nervous system neoplasm	0.000283	0.000682	CcSEcCtD
Ezogabine—Nervous system disorder—Doxorubicin—peripheral nervous system neoplasm	0.000282	0.00068	CcSEcCtD
Ezogabine—Thrombocytopenia—Doxorubicin—peripheral nervous system neoplasm	0.000281	0.000679	CcSEcCtD
Ezogabine—Paraesthesia—Epirubicin—peripheral nervous system neoplasm	0.000279	0.000673	CcSEcCtD
Ezogabine—Hyperhidrosis—Doxorubicin—peripheral nervous system neoplasm	0.000278	0.00067	CcSEcCtD
Ezogabine—Dyspnoea—Epirubicin—peripheral nervous system neoplasm	0.000277	0.000668	CcSEcCtD
Ezogabine—Somnolence—Epirubicin—peripheral nervous system neoplasm	0.000276	0.000666	CcSEcCtD
Ezogabine—Dyspepsia—Epirubicin—peripheral nervous system neoplasm	0.000273	0.00066	CcSEcCtD
Ezogabine—Gastrointestinal disorder—Epirubicin—peripheral nervous system neoplasm	0.000268	0.000647	CcSEcCtD
Ezogabine—Fatigue—Epirubicin—peripheral nervous system neoplasm	0.000268	0.000646	CcSEcCtD
Ezogabine—Constipation—Epirubicin—peripheral nervous system neoplasm	0.000266	0.000641	CcSEcCtD
Ezogabine—Paraesthesia—Doxorubicin—peripheral nervous system neoplasm	0.000258	0.000623	CcSEcCtD
Ezogabine—Dyspnoea—Doxorubicin—peripheral nervous system neoplasm	0.000256	0.000618	CcSEcCtD
Ezogabine—Feeling abnormal—Epirubicin—peripheral nervous system neoplasm	0.000256	0.000618	CcSEcCtD
Ezogabine—Somnolence—Doxorubicin—peripheral nervous system neoplasm	0.000256	0.000617	CcSEcCtD
Ezogabine—Dyspepsia—Doxorubicin—peripheral nervous system neoplasm	0.000253	0.00061	CcSEcCtD
Ezogabine—Gastrointestinal disorder—Doxorubicin—peripheral nervous system neoplasm	0.000248	0.000599	CcSEcCtD
Ezogabine—Fatigue—Doxorubicin—peripheral nervous system neoplasm	0.000248	0.000598	CcSEcCtD
Ezogabine—Constipation—Doxorubicin—peripheral nervous system neoplasm	0.000246	0.000593	CcSEcCtD
Ezogabine—CYP2A6—Constitutive Androstane Receptor Pathway—ABCB1—peripheral nervous system neoplasm	0.000242	0.0137	CbGpPWpGaD
Ezogabine—Feeling abnormal—Doxorubicin—peripheral nervous system neoplasm	0.000237	0.000572	CcSEcCtD
Ezogabine—Asthenia—Epirubicin—peripheral nervous system neoplasm	0.000223	0.000538	CcSEcCtD
Ezogabine—NAT2—Metabolism—PPIP5K2—peripheral nervous system neoplasm	0.000213	0.0121	CbGpPWpGaD
Ezogabine—KCNQ3—Axon guidance—NCAM1—peripheral nervous system neoplasm	0.000213	0.012	CbGpPWpGaD
Ezogabine—KCNQ2—Axon guidance—NCAM1—peripheral nervous system neoplasm	0.000213	0.012	CbGpPWpGaD
Ezogabine—Asthenia—Doxorubicin—peripheral nervous system neoplasm	0.000206	0.000498	CcSEcCtD
Ezogabine—UGT1A4—NRF2 pathway—SLC2A1—peripheral nervous system neoplasm	0.000206	0.0116	CbGpPWpGaD
Ezogabine—Dizziness—Epirubicin—peripheral nervous system neoplasm	0.000205	0.000496	CcSEcCtD
Ezogabine—KCNQ3—Neuronal System—BCHE—peripheral nervous system neoplasm	0.000199	0.0112	CbGpPWpGaD
Ezogabine—KCNQ2—Neuronal System—BCHE—peripheral nervous system neoplasm	0.000199	0.0112	CbGpPWpGaD
Ezogabine—Rash—Epirubicin—peripheral nervous system neoplasm	0.000196	0.000473	CcSEcCtD
Ezogabine—Dermatitis—Epirubicin—peripheral nervous system neoplasm	0.000196	0.000472	CcSEcCtD
Ezogabine—Dizziness—Doxorubicin—peripheral nervous system neoplasm	0.00019	0.000459	CcSEcCtD
Ezogabine—Nausea—Epirubicin—peripheral nervous system neoplasm	0.000185	0.000445	CcSEcCtD
Ezogabine—Rash—Doxorubicin—peripheral nervous system neoplasm	0.000181	0.000437	CcSEcCtD
Ezogabine—Dermatitis—Doxorubicin—peripheral nervous system neoplasm	0.000181	0.000437	CcSEcCtD
Ezogabine—UGT1A3—NRF2 pathway—SLC2A1—peripheral nervous system neoplasm	0.000171	0.00965	CbGpPWpGaD
Ezogabine—Nausea—Doxorubicin—peripheral nervous system neoplasm	0.000171	0.000412	CcSEcCtD
Ezogabine—UGT1A4—NRF2 pathway—HGF—peripheral nervous system neoplasm	0.000158	0.0089	CbGpPWpGaD
Ezogabine—KCNQ3—Developmental Biology—NCAM1—peripheral nervous system neoplasm	0.000152	0.0086	CbGpPWpGaD
Ezogabine—KCNQ2—Developmental Biology—NCAM1—peripheral nervous system neoplasm	0.000152	0.0086	CbGpPWpGaD
Ezogabine—UGT1A9—PPAR Alpha Pathway—MYC—peripheral nervous system neoplasm	0.000147	0.0083	CbGpPWpGaD
Ezogabine—NAT2—Metabolism—HSD17B12—peripheral nervous system neoplasm	0.000144	0.00814	CbGpPWpGaD
Ezogabine—UGT1A3—NRF2 pathway—HGF—peripheral nervous system neoplasm	0.000131	0.0074	CbGpPWpGaD
Ezogabine—UGT1A4—Metabolism—PPIP5K2—peripheral nervous system neoplasm	0.000129	0.0073	CbGpPWpGaD
Ezogabine—UGT1A1—NRF2 pathway—SLC2A1—peripheral nervous system neoplasm	0.000118	0.00667	CbGpPWpGaD
Ezogabine—UGT1A9—NRF2 pathway—SLC2A1—peripheral nervous system neoplasm	0.000118	0.00667	CbGpPWpGaD
Ezogabine—UGT1A9—Metabolism of lipids and lipoproteins—HSD17B12—peripheral nervous system neoplasm	0.000113	0.00636	CbGpPWpGaD
Ezogabine—UGT1A3—Metabolism—PPIP5K2—peripheral nervous system neoplasm	0.000107	0.00607	CbGpPWpGaD
Ezogabine—NAT2—Metabolism—GNS—peripheral nervous system neoplasm	0.000104	0.00589	CbGpPWpGaD
Ezogabine—KCNQ3—Axon guidance—MET—peripheral nervous system neoplasm	0.000102	0.00576	CbGpPWpGaD
Ezogabine—KCNQ2—Axon guidance—MET—peripheral nervous system neoplasm	0.000102	0.00576	CbGpPWpGaD
Ezogabine—NAT2—Metabolism—NME1—peripheral nervous system neoplasm	9.99e-05	0.00564	CbGpPWpGaD
Ezogabine—NAT2—Metabolism—COX2—peripheral nervous system neoplasm	9.62e-05	0.00543	CbGpPWpGaD
Ezogabine—KCNQ2—Axon guidance—PTPN11—peripheral nervous system neoplasm	9.42e-05	0.00532	CbGpPWpGaD
Ezogabine—KCNQ3—Axon guidance—PTPN11—peripheral nervous system neoplasm	9.42e-05	0.00532	CbGpPWpGaD
Ezogabine—CYP2A6—NRF2 pathway—SLC2A1—peripheral nervous system neoplasm	9.1e-05	0.00514	CbGpPWpGaD
Ezogabine—UGT1A1—NRF2 pathway—HGF—peripheral nervous system neoplasm	9.05e-05	0.00511	CbGpPWpGaD
Ezogabine—UGT1A9—NRF2 pathway—HGF—peripheral nervous system neoplasm	9.05e-05	0.00511	CbGpPWpGaD
Ezogabine—UGT1A4—Metabolism—HSD17B12—peripheral nervous system neoplasm	8.73e-05	0.00493	CbGpPWpGaD
Ezogabine—KCNQ5—Neuronal System—HRAS—peripheral nervous system neoplasm	8.65e-05	0.00489	CbGpPWpGaD
Ezogabine—KCNQ4—Neuronal System—HRAS—peripheral nervous system neoplasm	8.65e-05	0.00489	CbGpPWpGaD
Ezogabine—CYP2A6—Fluoropyrimidine Activity—TP53—peripheral nervous system neoplasm	7.69e-05	0.00434	CbGpPWpGaD
Ezogabine—KCNQ2—Axon guidance—ERBB2—peripheral nervous system neoplasm	7.45e-05	0.00421	CbGpPWpGaD
Ezogabine—KCNQ3—Axon guidance—ERBB2—peripheral nervous system neoplasm	7.45e-05	0.00421	CbGpPWpGaD
Ezogabine—UGT1A9—Metabolism—PPIP5K2—peripheral nervous system neoplasm	7.42e-05	0.00419	CbGpPWpGaD
Ezogabine—UGT1A1—Metabolism—PPIP5K2—peripheral nervous system neoplasm	7.42e-05	0.00419	CbGpPWpGaD
Ezogabine—KCNQ3—Developmental Biology—MET—peripheral nervous system neoplasm	7.27e-05	0.00411	CbGpPWpGaD
Ezogabine—KCNQ2—Developmental Biology—MET—peripheral nervous system neoplasm	7.27e-05	0.00411	CbGpPWpGaD
Ezogabine—UGT1A3—Metabolism—HSD17B12—peripheral nervous system neoplasm	7.26e-05	0.0041	CbGpPWpGaD
Ezogabine—CYP2A6—NRF2 pathway—HGF—peripheral nervous system neoplasm	6.97e-05	0.00394	CbGpPWpGaD
Ezogabine—KCNQ3—Developmental Biology—PTPN11—peripheral nervous system neoplasm	6.73e-05	0.0038	CbGpPWpGaD
Ezogabine—KCNQ2—Developmental Biology—PTPN11—peripheral nervous system neoplasm	6.73e-05	0.0038	CbGpPWpGaD
Ezogabine—UGT1A4—Metabolism—GNS—peripheral nervous system neoplasm	6.31e-05	0.00357	CbGpPWpGaD
Ezogabine—NAT2—Metabolism—ENO2—peripheral nervous system neoplasm	6.31e-05	0.00357	CbGpPWpGaD
Ezogabine—UGT1A4—Metabolism—NME1—peripheral nervous system neoplasm	6.05e-05	0.00342	CbGpPWpGaD
Ezogabine—UGT1A4—Metabolism—COX2—peripheral nervous system neoplasm	5.83e-05	0.00329	CbGpPWpGaD
Ezogabine—CYP2A6—Metabolism—PPIP5K2—peripheral nervous system neoplasm	5.72e-05	0.00323	CbGpPWpGaD
Ezogabine—KCNQ2—Axon guidance—NRAS—peripheral nervous system neoplasm	5.67e-05	0.0032	CbGpPWpGaD
Ezogabine—KCNQ3—Axon guidance—NRAS—peripheral nervous system neoplasm	5.67e-05	0.0032	CbGpPWpGaD
Ezogabine—NAT2—Metabolism—BCHE—peripheral nervous system neoplasm	5.33e-05	0.00301	CbGpPWpGaD
Ezogabine—KCNQ3—Developmental Biology—ERBB2—peripheral nervous system neoplasm	5.32e-05	0.003	CbGpPWpGaD
Ezogabine—KCNQ2—Developmental Biology—ERBB2—peripheral nervous system neoplasm	5.32e-05	0.003	CbGpPWpGaD
Ezogabine—UGT1A3—Metabolism—GNS—peripheral nervous system neoplasm	5.25e-05	0.00296	CbGpPWpGaD
Ezogabine—NAT2—Metabolism—SLC2A1—peripheral nervous system neoplasm	5.09e-05	0.00287	CbGpPWpGaD
Ezogabine—UGT1A3—Metabolism—NME1—peripheral nervous system neoplasm	5.03e-05	0.00284	CbGpPWpGaD
Ezogabine—UGT1A9—Metabolism—HSD17B12—peripheral nervous system neoplasm	5.02e-05	0.00283	CbGpPWpGaD
Ezogabine—NAT2—Metabolism—TH—peripheral nervous system neoplasm	5.02e-05	0.00283	CbGpPWpGaD
Ezogabine—UGT1A1—Metabolism—HSD17B12—peripheral nervous system neoplasm	5.02e-05	0.00283	CbGpPWpGaD
Ezogabine—UGT1A3—Metabolism—COX2—peripheral nervous system neoplasm	4.84e-05	0.00274	CbGpPWpGaD
Ezogabine—KCNQ2—Neuronal System—HRAS—peripheral nervous system neoplasm	4.67e-05	0.00264	CbGpPWpGaD
Ezogabine—KCNQ3—Neuronal System—HRAS—peripheral nervous system neoplasm	4.67e-05	0.00264	CbGpPWpGaD
Ezogabine—UGT1A9—Metabolism of lipids and lipoproteins—BCHE—peripheral nervous system neoplasm	4.17e-05	0.00235	CbGpPWpGaD
Ezogabine—KCNQ2—Axon guidance—HRAS—peripheral nervous system neoplasm	4.15e-05	0.00234	CbGpPWpGaD
Ezogabine—KCNQ3—Axon guidance—HRAS—peripheral nervous system neoplasm	4.15e-05	0.00234	CbGpPWpGaD
Ezogabine—NAT2—Metabolism—GNAS—peripheral nervous system neoplasm	4.09e-05	0.00231	CbGpPWpGaD
Ezogabine—KCNQ2—Developmental Biology—NRAS—peripheral nervous system neoplasm	4.04e-05	0.00228	CbGpPWpGaD
Ezogabine—KCNQ3—Developmental Biology—NRAS—peripheral nervous system neoplasm	4.04e-05	0.00228	CbGpPWpGaD
Ezogabine—NAT2—Metabolism—ABCB1—peripheral nervous system neoplasm	4.02e-05	0.00227	CbGpPWpGaD
Ezogabine—CYP2A6—Metabolism—HSD17B12—peripheral nervous system neoplasm	3.87e-05	0.00218	CbGpPWpGaD
Ezogabine—UGT1A4—Metabolism—ENO2—peripheral nervous system neoplasm	3.82e-05	0.00216	CbGpPWpGaD
Ezogabine—UGT1A1—Metabolism—GNS—peripheral nervous system neoplasm	3.63e-05	0.00205	CbGpPWpGaD
Ezogabine—UGT1A9—Metabolism—GNS—peripheral nervous system neoplasm	3.63e-05	0.00205	CbGpPWpGaD
Ezogabine—UGT1A1—Metabolism—NME1—peripheral nervous system neoplasm	3.48e-05	0.00196	CbGpPWpGaD
Ezogabine—UGT1A9—Metabolism—NME1—peripheral nervous system neoplasm	3.48e-05	0.00196	CbGpPWpGaD
Ezogabine—UGT1A9—Metabolism—COX2—peripheral nervous system neoplasm	3.35e-05	0.00189	CbGpPWpGaD
Ezogabine—UGT1A1—Metabolism—COX2—peripheral nervous system neoplasm	3.35e-05	0.00189	CbGpPWpGaD
Ezogabine—UGT1A4—Metabolism—BCHE—peripheral nervous system neoplasm	3.23e-05	0.00183	CbGpPWpGaD
Ezogabine—UGT1A3—Metabolism—ENO2—peripheral nervous system neoplasm	3.18e-05	0.0018	CbGpPWpGaD
Ezogabine—UGT1A4—Metabolism—SLC2A1—peripheral nervous system neoplasm	3.08e-05	0.00174	CbGpPWpGaD
Ezogabine—UGT1A4—Metabolism—TH—peripheral nervous system neoplasm	3.04e-05	0.00172	CbGpPWpGaD
Ezogabine—KCNQ3—Developmental Biology—HRAS—peripheral nervous system neoplasm	2.96e-05	0.00167	CbGpPWpGaD
Ezogabine—KCNQ2—Developmental Biology—HRAS—peripheral nervous system neoplasm	2.96e-05	0.00167	CbGpPWpGaD
Ezogabine—CYP2A6—Metabolism—GNS—peripheral nervous system neoplasm	2.79e-05	0.00158	CbGpPWpGaD
Ezogabine—UGT1A3—Metabolism—BCHE—peripheral nervous system neoplasm	2.69e-05	0.00152	CbGpPWpGaD
Ezogabine—CYP2A6—Metabolism—NME1—peripheral nervous system neoplasm	2.68e-05	0.00151	CbGpPWpGaD
Ezogabine—KCNQ2—Developmental Biology—AKT1—peripheral nervous system neoplasm	2.61e-05	0.00148	CbGpPWpGaD
Ezogabine—KCNQ3—Developmental Biology—AKT1—peripheral nervous system neoplasm	2.61e-05	0.00148	CbGpPWpGaD
Ezogabine—CYP2A6—Metabolism—COX2—peripheral nervous system neoplasm	2.58e-05	0.00146	CbGpPWpGaD
Ezogabine—UGT1A3—Metabolism—SLC2A1—peripheral nervous system neoplasm	2.56e-05	0.00145	CbGpPWpGaD
Ezogabine—UGT1A3—Metabolism—TH—peripheral nervous system neoplasm	2.53e-05	0.00143	CbGpPWpGaD
Ezogabine—UGT1A4—Metabolism—GNAS—peripheral nervous system neoplasm	2.48e-05	0.0014	CbGpPWpGaD
Ezogabine—UGT1A4—Metabolism—ABCB1—peripheral nervous system neoplasm	2.43e-05	0.00137	CbGpPWpGaD
Ezogabine—UGT1A1—Metabolism—ENO2—peripheral nervous system neoplasm	2.2e-05	0.00124	CbGpPWpGaD
Ezogabine—UGT1A9—Metabolism—ENO2—peripheral nervous system neoplasm	2.2e-05	0.00124	CbGpPWpGaD
Ezogabine—UGT1A3—Metabolism—GNAS—peripheral nervous system neoplasm	2.06e-05	0.00116	CbGpPWpGaD
Ezogabine—UGT1A3—Metabolism—ABCB1—peripheral nervous system neoplasm	2.02e-05	0.00114	CbGpPWpGaD
Ezogabine—UGT1A9—Metabolism—BCHE—peripheral nervous system neoplasm	1.86e-05	0.00105	CbGpPWpGaD
Ezogabine—UGT1A1—Metabolism—BCHE—peripheral nervous system neoplasm	1.86e-05	0.00105	CbGpPWpGaD
Ezogabine—UGT1A1—Metabolism—SLC2A1—peripheral nervous system neoplasm	1.77e-05	0.001	CbGpPWpGaD
Ezogabine—UGT1A9—Metabolism—SLC2A1—peripheral nervous system neoplasm	1.77e-05	0.001	CbGpPWpGaD
Ezogabine—UGT1A9—Metabolism—TH—peripheral nervous system neoplasm	1.75e-05	0.000986	CbGpPWpGaD
Ezogabine—UGT1A1—Metabolism—TH—peripheral nervous system neoplasm	1.75e-05	0.000986	CbGpPWpGaD
Ezogabine—CYP2A6—Metabolism—ENO2—peripheral nervous system neoplasm	1.69e-05	0.000957	CbGpPWpGaD
Ezogabine—CYP2A6—Metabolism—BCHE—peripheral nervous system neoplasm	1.43e-05	0.000808	CbGpPWpGaD
Ezogabine—UGT1A1—Metabolism—GNAS—peripheral nervous system neoplasm	1.42e-05	0.000805	CbGpPWpGaD
Ezogabine—UGT1A9—Metabolism—GNAS—peripheral nervous system neoplasm	1.42e-05	0.000805	CbGpPWpGaD
Ezogabine—UGT1A9—Metabolism—ABCB1—peripheral nervous system neoplasm	1.4e-05	0.00079	CbGpPWpGaD
Ezogabine—UGT1A1—Metabolism—ABCB1—peripheral nervous system neoplasm	1.4e-05	0.00079	CbGpPWpGaD
Ezogabine—CYP2A6—Metabolism—SLC2A1—peripheral nervous system neoplasm	1.36e-05	0.000771	CbGpPWpGaD
Ezogabine—CYP2A6—Metabolism—TH—peripheral nervous system neoplasm	1.35e-05	0.00076	CbGpPWpGaD
Ezogabine—NAT2—Metabolism—AKT1—peripheral nervous system neoplasm	1.11e-05	0.000624	CbGpPWpGaD
Ezogabine—CYP2A6—Metabolism—GNAS—peripheral nervous system neoplasm	1.1e-05	0.00062	CbGpPWpGaD
Ezogabine—CYP2A6—Metabolism—ABCB1—peripheral nervous system neoplasm	1.08e-05	0.000609	CbGpPWpGaD
Ezogabine—UGT1A4—Metabolism—AKT1—peripheral nervous system neoplasm	6.7e-06	0.000378	CbGpPWpGaD
Ezogabine—UGT1A3—Metabolism—AKT1—peripheral nervous system neoplasm	5.57e-06	0.000314	CbGpPWpGaD
Ezogabine—UGT1A1—Metabolism—AKT1—peripheral nervous system neoplasm	3.85e-06	0.000217	CbGpPWpGaD
Ezogabine—UGT1A9—Metabolism—AKT1—peripheral nervous system neoplasm	3.85e-06	0.000217	CbGpPWpGaD
Ezogabine—CYP2A6—Metabolism—AKT1—peripheral nervous system neoplasm	2.96e-06	0.000167	CbGpPWpGaD
